Explain this page
Arphra AIPlain-English read on Medtronic plc’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.23% | -2.08% | -7.53% | -24.59% | -27.49% | -22.99% | -11.66% | -11.68% | -40.24% | -10.86% | +23499.59% |
Aftermarket
LiveLast trade
$74.18
160 sh
Bid
$74.01
400 sh
Ask
$74.19
500 sh
Spread
$0.180
Sector & industry today
LiveSectors
- Technology+3.30%
- Basic Materials+0.98%
- Energy+0.83%
- Consumer Cyclical+0.49%
- Industrials+0.25%
- Communication Services+0.13%
- Healthcare-0.65%
- Financial Services-0.80%
- Consumer Defensive-0.84%
- Utilities-1.15%
- Real Estate-1.32%
Top industries (issuer's industry highlighted)
- Medical - Devices-0.34%
- Computer Hardware+8.35%
- Software - Infrastructure+7.61%
- Consulting Services+5.28%
- Coal+5.20%
- Manufacturing - Metal Fabrication+4.24%
- Staffing & Employment Services+4.08%
- Gambling, Resorts & Casinos+3.71%
- Broadcasting+3.70%
- Integrated Freight & Logistics+3.68%
- REIT - Healthcare Facilities-3.49%
- Software - Application+3.44%
Fair value
Football field →Weighted blend
$145.94
+97.27% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
11bull7bear
±5% threshold
Analyst PT consensus: $109.50 (+48.01%)
Total assets
$91.68B
Total debt
$28.52B
Cash & equiv
$2.22B
Operating CF
$7.04B
Free cash flow
$5.19B
Buybacks
-$3.24B
Analyst view
DB · price_targets + analyst_gradesConsensus target
$109.50
+48.01% upside
Low
$95.00
Median
$111.50
High
$120.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 Jan 2026 | $9.02B | $1.14B | $0.89 |
| Q2 Oct 2025 | $8.96B | $1.37B | $1.07 |
| Q1 Jul 2025 | $8.58B | $1.04B | $0.81 |
| Q4 Apr 2025 | $8.93B | $1.06B | $0.82 |
| Q3 Jan 2025 | $8.29B | $1.29B | $1.01 |
| Q2 Oct 2024 | $8.4B | $1.27B | $0.99 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
KIIL HARRY SKIP officer: EVP & President Cardiovascular | Sell | 1,648 | $161.27K | Feb 19, 2026 |
KIIL HARRY SKIP officer: EVP & President Cardiovascular | Sell | 385 | $37.66K | Feb 19, 2026 |
KIIL HARRY SKIP officer: EVP & President Cardiovascular | Sell | 19,255 | $1.88M | Feb 19, 2026 |
KIIL HARRY SKIP officer: EVP & President Cardiovascular | Sell | 30,568 | $2.99M | Feb 19, 2026 |
KIIL HARRY SKIP officer: EVP & President Cardiovascular | Sell | 668 | $65.35K | Feb 19, 2026 |
Smith Gregory L officer: EVP Global Ops & Supply Chain | Sell | 325 | $33.17K | Nov 19, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $33.54B | $5.96B | $4.66B | $3.61 | +13.90% |
| FY 2024 | $32.36B | $5.14B | $3.68B | $2.76 | +11.36% |
| FY 2023 | $31.23B | $5.49B | $3.76B | $2.82 | +12.03% |
| FY 2022 | $31.69B | $5.75B | $5.04B | $3.73 | +15.90% |
| FY 2021 | $30.12B | $4.48B | $3.61B | $2.66 | +11.97% |